Skip to main content

15:00 pm – 16:00 pm

This will be a virtual conference. Details about the platform will be provided after completion of the registration.


Androgenetic Alopecia, also known as pattern hair loss, is the most common form of hair loss. It affects up to 70 % of all men and 40 % of all women. The condition can be treated in many different ways. There are for example medical devices treating hair loss and promoting hair growth. Patients may also make use of medicinal products, which may be applied topically or orally. Over the Counter Products and Food Supplements can also be used for the treatment of androgenetic alopecia.



In this webinar, we would like to shed light on the different perspectives and testing approaches of clinical studies with products targeting Androgenetic Alopecia. Our speakers Sandra Bleckwenn and Dr. Matthias Seise will be joined by Michal Kasprzak from Tricholab, in order to discuss the following aspects in the one-hour webinar:

  • Anatomy of the skin, the scalp, hairs and follicles
  • Objective and subjective assessments
  • Parameters/ Methods:
    • Clinical Photography / Image Analysis / Phototrichogram (PT)- Recruitment of patients and subjects
  • Patients with hair loss (e.g. androgenetic alopecia)
  • Study designs:
    • Use tests (application in the test area or systemic intake)
    • Efficacy studies: Claims, Intended Use, Indications
  • Questions and answers

Participation in this webinar is particularly interesting for manufacturers of the following products:

  • Medical devices and Over the Counter (OTC) products with efficacy to hair growth
  • Food supplements with impact to hair quality
  • Medicinal products for the treatment of hair loss
  • Topical products such as scalp lotions, sera, hair waters, shampoos etc.

Participation in the webinar is free of charge.


Sandra Bleckwenn

Key Account Manager Medical | SGS proderm

Matthias Seise

Group Leader Development and Technical Services | SGS proderm

Michal Kasprzak

CEO | TrichoLAB


proderm is now part of SGS proderm is now part of SGS